Intech Investment Management LLC Buys 57,726 Shares of agilon health, inc. (NYSE:AGL)

Intech Investment Management LLC increased its stake in agilon health, inc. (NYSE:AGL) by 99.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 115,693 shares of the company’s stock after acquiring an additional 57,726 shares during the period. Intech Investment Management LLC’s holdings in agilon health were worth $220,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Symphony Financial Services Inc. increased its position in shares of agilon health by 44.3% during the 4th quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock valued at $44,000 after purchasing an additional 7,058 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in agilon health during the third quarter valued at approximately $28,000. Signaturefd LLC raised its stake in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after acquiring an additional 8,467 shares in the last quarter. Oak Thistle LLC bought a new stake in shares of agilon health in the 4th quarter worth approximately $25,000. Finally, Ieq Capital LLC purchased a new stake in shares of agilon health in the 4th quarter valued at $26,000.

agilon health Stock Performance

Shares of AGL opened at $4.53 on Thursday. agilon health, inc. has a one year low of $1.50 and a one year high of $7.73. The company has a 50-day simple moving average of $3.61 and a two-hundred day simple moving average of $2.96. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market capitalization of $1.87 billion, a PE ratio of -4.82 and a beta of 0.67.

Analyst Ratings Changes

AGL has been the topic of a number of analyst reports. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Macquarie started coverage on agilon health in a report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Stifel Nicolaus lifted their price target on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Sanford C. Bernstein increased their price objective on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Finally, Royal Bank of Canada lifted their target price on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, agilon health presently has a consensus rating of “Hold” and an average price target of $3.95.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.